Adapting to the multichannel imperative: A special report | Reuters Events | Pharma
After diagnosing a chronic disease, a treatment pathway is set and over time, all being well, the patient responds and returns to better health. Before the pandemic, pharma’s commercial leaders had been addressing their own slowly progressing disease - the increasing difficulty MRs have faced in reaching busy, overworked and ever more disengaged HCPs. But a heart attack is a
Reaction
(1)
No comment yet.
Sign up to comment
